MedTrace Logo

Early Diagnosis of PPD Through Self-portraits

NCT03791021 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-06-09

No results posted yet for this study

Summary

the target of the research is development of a predictive tool for early identification of women which are at higher risk for development of postpartum depression.

the evaluating tools include self portraits and questionnaire during the third trimester of pregnancy.

The suggested research aims to evaluate if and how it would be possible to predict the potential for postpartum mood swing disorders in pregnant women while in the third trimester. The later to prevent the mother from enduring such a detrimental experience, which influences the child development, the family as well as the mother's intimate relationship.

The aim is to identify indicators to predict such potential, using questionnaires and self-portraits during pregnancy, to allow early intervention and treatment. Early diagnosis and quick treatment of pregnant women or post-partum mothers will allow them a higher level of functioning and may even prevent eventually infant neurological and developmental delays and hardships.

Conditions

Interventions

DIAGNOSTIC_TEST

draw a person (DAP)

the subjects will be given a blank sheet of white paper and a pencil, and will be asked to draw themselves with no other additional instructions.

DIAGNOSTIC_TEST

Edinburgh Postnatal Depression Scale (EPDS)

measure of postpartum depression symptoms.

DIAGNOSTIC_TEST

Beck Depression Inventory- II (BDI-II)

BDI-II is based on clinical observations of behaviors associated with depression, and it retains the somatic items in accordance with the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria related to loss of energy. ansd sleep disturbances.

DIAGNOSTIC_TEST

Traumatic Events Questionnaire (TEQ)

The TEQ assesses experiences with nine specific types of traumatic events (e.g., accidents, crime, adult abusive experiences) reported in the empirical literature as having the potential to elicit PTSD symptoms.

Sponsors & Collaborators

  • University of Haifa

    collaborator OTHER

  • Sheba Medical Center

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03791021 on ClinicalTrials.gov